<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Physiology and Pharmacology</title>
<title_fa></title_fa>
<short_title>Physiol Pharmacol</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ppj.phypha.ir</web_url>
<journal_hbi_system_id>32</journal_hbi_system_id>
<journal_hbi_system_user>journal32</journal_hbi_system_user>
<journal_id_issn>24765236</journal_id_issn>
<journal_id_issn_online>24765244</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.22034</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>(previous ISSN: 17350581)</journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1398</year>
	<month>9</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2019</year>
	<month>12</month>
	<day>1</day>
</pubdate>
<volume>23</volume>
<number>4</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>The role of muscarinic and serotonergic-2A receptors in the antinociceptive effect of pregabalin</title>
	<subject_fa>Pharmacokinetics/Dynamics</subject_fa>
	<subject>Pharmacokinetics/Dynamics</subject>
	<content_type_fa>Experimental research article</content_type_fa>
	<content_type>Experimental research article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Pregabalin (PGB) is an analog of gamma-aminobutyric acid (GABA) with antinociceptive, antihyperalgesic and antiallodynic properties which frequently used in clinical pain management. Effect of PBG in neuropathic pain, incisional-inflammatory injury, post-operational pain, chronic pain and experimental pain models have already shown. It has been already known that muscarinic and serotonergic-2A receptors have a role in pain transmission. &lt;strong&gt;Methods:&lt;/strong&gt; in this study, role of muscarinic and serotonergic-2A receptors in antinociceptive effect of pregabalin were evaluated with hot-plate and tail flick tests and effects of administered drugs on locomotor activity were measured with automated activity cage. &lt;strong&gt;Results:&lt;/strong&gt; PGB treatment (30 and 100mg/kg) caused longer latency in hot plate and tail flick tests than saline group. That antinociceptive effect of pregabalin abolished by ketanserin (1mg/kg) and atropine (1mg/kg) treatment. &lt;strong&gt;Conclusion:&lt;/strong&gt; However, there is lack of knowledge about role of nociceptive pathways underlying pregabalin mediated antinociception. Our results suggest that cholinergic and serotonergic systems have a role in antinociceptive effect of PGB which has seen in these somatic pain tests.&lt;/div&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Pregabalin, Somatic pain, Ketanserin, Atropine.</keyword>
	<start_page>302</start_page>
	<end_page>308</end_page>
	<web_url>http://ppj.phypha.ir/browse.php?a_code=A-10-1207-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Mohamad</first_name>
	<middle_name></middle_name>
	<last_name>Hallak</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>3200319475328460029663</code>
	<orcid>3200319475328460029663</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Erciyes University, School of Medicine, Deparment of Pharmacology 38039 Melikgazi, Kayserı, Turkey</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Hakan</first_name>
	<middle_name></middle_name>
	<last_name>Balci</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>3200319475328460029664</code>
	<orcid>3200319475328460029664</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Ondokuz Mayıs University, School of Medicine, Deparment of Pharmacology 55139, Atakum, Samsun, Turkey</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Caner</first_name>
	<middle_name></middle_name>
	<last_name>Günaydın</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>3200319475328460029665</code>
	<orcid>3200319475328460029665</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Ondokuz Mayıs University, School of Medicine, Deparment of Pharmacology 55139, Atakum, Samsun, Turkey</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>S. Sirri </first_name>
	<middle_name></middle_name>
	<last_name>Bilge</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>ssbilge@omu.edu.tr</email>
	<code>3200319475328460029666</code>
	<orcid>3200319475328460029666</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Ondokuz Mayıs University, School of Medicine, Deparment of Pharmacology 55139, Atakum, Samsun, Turkey</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
